This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
Since January 1, the price of JetBlue Airways Corporation (JBLU) has grown 41.6%. JetBlue Airways provides nonstop passenger flight service through its Airbus A320 aircraft. For more information, get Portfolio Grader’s complete analysis of JBLU stock.
Shares of Impax Laboratories, Inc. (IPXL) have leaped 44.1% since January 1. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The volume of trades has grown significantly in the past week, up 278.4%. For more information, get Portfolio Grader’s complete analysis of IPXL stock.
Shares of Ellie Mae, Inc. (ELLI) have risen 49.5% since January 1. Ellie Mae provides business automation software for the mortgage industry in the United States. For more information, get Portfolio Grader’s complete analysis of ELLI stock.
China Biologic Products, Inc. (CBPO) has risen 52% since the first of the year. China Biologic Products is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. For more information, get Portfolio Grader’s complete analysis of CBPO stock.
Since January 1, Stamps.com (STMP) has shot up 54.9%. Stamps.com is an Internet-based company that allows customers to send mail. For more information, get Portfolio Grader’s complete analysis of STMP stock.
Since the first of the year, shares of Insperity, Inc. (NSP) have soared 55.7%. Insperity provides personnel management that encompasses a range of services, including benefits and payroll administration, health and workers’ compensation insurance programs and personnel records management. For more information, get Portfolio Grader’s complete analysis of NSP stock.
Since the first of the year, the price of Skechers U.S.A., Inc. Class A (SKX) has swelled 75.8%. Skechers USA designs, makes, markets and distributes footwear. For more information, get Portfolio Grader’s complete analysis of SKX stock.
The price of ABIOMED, Inc. (ABMD) is up 83.7% since the first of the year. Abiomed provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. For more information, get Portfolio Grader’s complete analysis of ABMD stock.
Since January 1, Ebix, Inc. (EBIX) has jumped 87.4%. Ebix provides a series of application software products for the insurance industry, including carrier systems and agency systems. For more information, get Portfolio Grader’s complete analysis of EBIX stock.
The price of Chimera Investment Corporation (CIM) has seen a 344.1% boost since the first of the year. Chimera Investment is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.20. For more information, get Portfolio Grader’s complete analysis of CIM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
